Abstract
BackgroundApproximately 20% of lupus nephritis (LN) patients develop end-stage renal disease (ESRD) within 10 years. As LN progresses, anemia is common. Little is known, however, about utilization patterns of erythropoiesis-stimulating...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have